Non-atheroprotective effects of statins: a systematic review.


Since the introduction of HMG-CoA reductase inhibitors (statins) for lowering lipids, a large amount of data has been published demonstrating their potential benefits in conditions as varied as cancer, osteoporosis, and Alzheimer's dementia. We reviewed the published literature on MEDLINE from articles between 1950 and 2008 on the non-atheroprotective… (More)
DOI: 10.2165/11315710-000000000-00000


Cite this paper

@article{Beri2009NonatheroprotectiveEO, title={Non-atheroprotective effects of statins: a systematic review.}, author={Abhimanyu Beri and Neethi Sural and Snigdha B Mahajan}, journal={American journal of cardiovascular drugs : drugs, devices, and other interventions}, year={2009}, volume={9 6}, pages={361-70} }